Literature DB >> 14597926

Percutaneous coronary intervention: historical perspectives, current status, and future directions.

Heidar Arjomand1, Zoltan G Turi, Daniel McCormick, Sheldon Goldberg.   

Abstract

In the twenty-six years since Gruntzig introduced a simple balloon angioplasty technique, percutaneous coronary intervention has undergone extraordinary growth and has now surpassed bypass surgery in frequency of performance. Several critical breakthrough technologies account for this remarkable progress: intracoronary stents have increased success rates and reduced restenosis, adjunctive antiplatelet therapy has reduced periprocedural complications, and restenosis after stent placement has been effectively treated with local radiation. Most recently, drug-eluting stents coated with cell-cycle inhibitors have shown great promise for further reducing restenosis, possibly to negligible levels.

Entities:  

Mesh:

Year:  2003        PMID: 14597926     DOI: 10.1016/S0002-8703(03)00153-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions.

Authors:  Aylin Yildirir; Sadik Acikel; Cagatay Ertan; Alp Aydinalp; Bulent Ozin; Haldun Muderrisoglu
Journal:  Tex Heart Inst J       Date:  2007

2.  Real world experience with an indigenously manufactured stent Cobal C--a retrospective study.

Authors:  B K S Sastry; Nirmal Kumar; Rajeev Menon; Anuj Kapadia; C Sridevi; G Surya Prakash; N Krishna Reddy; M Srinivasa Rao
Journal:  Indian Heart J       Date:  2014-09-18

3.  A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention.

Authors:  M Lourdes Sampietro; Stella Trompet; Jeffrey J W Verschuren; Rudolf P Talens; Joris Deelen; Bastiaan T Heijmans; Robbert J de Winter; Rene A Tio; Pieter A F M Doevendans; Santhi K Ganesh; Elizabeth G Nabel; Harm-Jan Westra; Lude Franke; Erik B van den Akker; Rudi G J Westendorp; Aeilko H Zwinderman; Adnan Kastrati; Werner Koch; P Eline Slagboom; Peter de Knijff; J Wouter Jukema
Journal:  Hum Mol Genet       Date:  2011-08-30       Impact factor: 6.150

4.  Perioperative management of antiplatelet therapy in patients with drug-eluting stents.

Authors:  G Dimitrova; D B Tulman; S D Bergese
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

5.  Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention.

Authors:  Fernando S Montenegro; Marcelo Correia; Fabiana Muccillo; Christina G Souza E Silva; Andrea De Lorenzo
Journal:  BMC Res Notes       Date:  2018-05-08

6.  A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease.

Authors:  Johan Bennett; Christophe Dubois
Journal:  Biologics       Date:  2013-06-19

7.  Application of in silico Platform for the Development and Optimization of Fully Bioresorbable Vascular Scaffold Designs.

Authors:  Miljan Milosevic; Milos Anic; Dalibor Nikolic; Vladimir Geroski; Bogdan Milicevic; Milos Kojic; Nenad Filipovic
Journal:  Front Med Technol       Date:  2021-10-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.